Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, November 11 at 2:00 PM ET

Register Free →

This Award Notice opportunity from Department Of Defense was posted on October 6, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

MOXIFLOXACIN HYDROC

Awarded
SPE2DP-26-T-5203Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325412
New
Federal
6505--Nitroglycerin Patches
Solicitation # 36E79727R0010
The Department of Veterans Affairs National Acquisition Center is initiating an unrestricted procurement for Nitroglycerin Patches under solicitation 36E79727R0010. This contract will serve the VA, including Consolidated Mail Order Pharmacies and Option 2 State Veterans Homes, as well as the Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center. The award will be granted to a single responsible offeror capable of providing an uninterrupted source of supply for a one-year base period followed by four pre-priced one-year option periods. Distribution will be managed through the VA and DoD Pharmaceutical Prime Vendor Programs. The procurement covers four strengths of Nitroglycerin patches (0.1 mg, 0.2 mg, 0.4 mg, and 0.6 mg), with estimated annual usage ranging from 2,213 to 10,044 boxes. All patches must be supplied in boxes of 30 and must feature barcoding on both the individual patch and the outside box. Strict labeling requirements apply: the contractor must provide a unique NDC number, and their label must be the only one on the product, without being affixed over another label. Additionally, the labels must allow VA labels to adhere securely over them. This solicitation will be issued in commercial item format per FAR Part 12, with a tentative issuance date of December 1, 2026, and a closing date of December 15, 2026.
Nac Pharmaceuticals (36E797)

POSTED

about 19 hours ago

DEADLINE

in 8 days

AI Contract Overview

Show more

Solicitation SPE2DP-26-T-5203 is a Request for Quotations issued by the DLA Troop Support Medical Supply Chain for the procurement of Moxifloxacin Hydrochloride 400 mg tablets. The requirement specifies bottles containing 30 tablets each, with a non-extendable shelf life of 36 months. The items must be stored at controlled room temperature and protected from high humidity. Delivery is required within 20 days of order to various destinations, including the USS Lewis B Puller (ESB 3), USS Sampson (DDG 102), and other military installations in North Carolina and Kentucky. The terms are FOB Destination, with inspection and acceptance also occurring at the destination. The procurement is governed by NAICS code 325412 and incorporates strict packaging and marking standards. All materials must be marked according to Medical Marking Standard No. 1, which supersedes MIL-STD-129. Packaging must comply with DLA Packaging Requirements for Procurement (RP001) and ASTM D3951 for non-hazardous materials, while hazardous materials must follow TQ requirement IP025. Payment and receiving reports must be processed electronically through the Wide Area WorkFlow (WAWF) system. The solicitation includes various federal and defense clauses, including the Buy American Act, DFARS safeguarding of covered defense information, and specific requirements for small business joint ventures.

General Info

DLA procurement of Moxifloxacin 400mg tablets delivered to various military destinations.

Contract Value

$2,132

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Place of Performance

AE, USA

Set-Aside

NONE

Award Issued Date

Documents

2
PDF, High priority: read this firstaward
High
PDF, High priority: read this first27 pages · rfq
High

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

4 updates
PhaseAwarded
Posted

Solicitation

Notice updated

The notice description changed.

Notice updated

The notice description changed.

Notice updated

The notice description changed.

Notice updated

The notice description changed.

Awarded

Contract was awarded

Find active opportunities like this

Get full access to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → Defense Logistics Agency
Contacts1 person available
OfficeUSA
Office AddressUSA
Contacts

Full Description

Show more
DLA award SPE2DP27P0095 posted on DIBBS. Awardee: OAKRIDGE DYNAMICS LLC (CAGE 8H3Q8) Total Contract Price: $2,132.00 Award Date: 10-06-2026 Solicitation: SPE2DP-26-T-5203 Line items: - MOXIFLOXACIN HYDROC (NSN/Part 6505015034772, PR 7016699423) - MOXIFLOXACIN HYDROC (NSN/Part 6505015034772, PR 7016740478) - MOXIFLOXACIN HYDROC (NSN/Part 6505015034772, PR 7016724053) - MOXIFLOXACIN HYDROC (NSN/Part 6505015034772, PR 7016677258) - MOXIFLOXACIN HYDROC (NSN/Part 6505015034772, PR 7016539944)

More opportunities from Department Of Defense → Defense Logistics Agency

Same awarding agency

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS